BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2837830)

  • 1. Surgical adjuvant chemotherapy in non-small cell lung cancer.
    Holmes EC
    Semin Oncol; 1988 Jun; 15(3):255-60. PubMed ID: 2837830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. An LCSG Trial.
    Feld R; Rubinstein L; Thomas PA
    Chest; 1994 Dec; 106(6 Suppl):307S-309S. PubMed ID: 7988250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of CAP chemotherapy and radiotherapy to radiotherapy alone for resected lung cancer with positive margin or involved highest sampled paratracheal node (stage IIIA). LCSG 791.
    Lad T
    Chest; 1994 Dec; 106(6 Suppl):302S-306S. PubMed ID: 7988249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival.
    Ichinose Y; Hara N; Ohta M; Motohiro A; Kuda T; Aso H
    J Surg Oncol; 1991 Jan; 46(1):15-20. PubMed ID: 1702493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence.
    Sadeghi A; Payne D; Rubinstein L; Lad T
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):89-97. PubMed ID: 2839444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer].
    Yamaguchi M; Fukuyama Y; Ichinose Y
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):203-8. PubMed ID: 12610867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy.
    Socinski MA
    Clin Lung Cancer; 2004 Mar; 5(5):274-89. PubMed ID: 15086966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer. A phase 2 study of the LCSG.
    Weiden PL; Piantadosi S
    Chest; 1994 Dec; 106(6 Suppl):344S-347S. PubMed ID: 7988261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer.
    Erman M; Moretti L; Soria JC; Le Chevalier T; Van Houtte P
    Semin Radiat Oncol; 2004 Oct; 14(4):315-21. PubMed ID: 15558506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized comparison of the effects of adjuvant therapy on resected stages II and III non-small cell carcinoma of the lung. The Lung Cancel Study Group.
    Holmes EC; Hill LD; Gail M
    Ann Surg; 1985 Sep; 202(3):335-41. PubMed ID: 3899029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer.
    Bernstein ED; Herbert SM; Hanna NH
    Ann Surg Oncol; 2006 Mar; 13(3):291-301. PubMed ID: 16450219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer.
    Park JH; Lee CT; Lee HW; Baek HJ; Zo JI; Shim YM
    Eur J Cardiothorac Surg; 2005 Jun; 27(6):1086-91. PubMed ID: 15896623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical adjuvant therapy of non-small-cell lung cancer.
    Holmes EC
    J Surg Oncol Suppl; 1989; 1():26-33. PubMed ID: 2548520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postoperative adjuvant treatment for non-small cell lung cancer].
    Ichinose Y
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2470-4. PubMed ID: 12506468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative chemotherapy for non-small-cell lung cancer.
    Holmes EC
    Chest; 1993 Jan; 103(1 Suppl):30S-34S. PubMed ID: 8380131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent changes in the management of advanced non-small cell lung cancer].
    Kodama N; Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2564-70. PubMed ID: 7979414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of regionally advanced (stage III) non-small cell lung cancer. LCSG 831.
    Eagan RT
    Chest; 1994 Dec; 106(6 Suppl):340S-343S. PubMed ID: 7988260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.